Modulation of c-Src tyrosine kinase activity alters MMP-9 activity in a variety of tumour cell types, including pancreatic adenocarcinoma cells (Ito et al, 2003; Recchia et al, 2003). This evidence concerns the gene MMP9 and neoplasm.